HB2617 • 2026

insurance; prostate cancer; cost sharing

HB2617 - insurance; prostate cancer; cost sharing

Healthcare

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Walt Blackman
Last action: 2026-03-09
Official status: House committee of the whole
Effective date: Not listed

Plain English Breakdown

The official text does not specify an effective date for the law itself, only that it applies to policies issued, amended, or renewed on or after January 1, 2027.

HB2617: No Cost Sharing for Prostate Cancer Screenings for High-Risk Men

This law stops health insurers from charging fees like copayments or deductibles for diagnostic prostate cancer screenings for men who meet specific high-risk criteria on policies issued, amended, or renewed starting January 1, 2027.

What This Bill Does

Prohibits insurers from requiring cost sharing for diagnostic prostate cancer screenings for high-risk subscribers on contracts issued, amended, or renewed on or after January 1, 2027.
Defines 'high-risk' men as those aged at least 40 who are of African ancestry, carry the BRCA1 or BRCA2 gene, have a family history of prostate cancer, or are military veterans exposed to Agent Orange.
Clarifies that having a family history includes a first-degree relative diagnosed with prostate cancer before age 60, died from it, developed related cancers, or has specific genetic mutations associated with increased risk.
States that this rule does not apply if the screening is performed by an out-of-network provider.

Who It Names or Affects

Health care insurers including hospital service corporations and medical service corporations
Disability insurers, group disability insurers, blanket disability insurers, and health care services organizations
Men aged at least 40 who meet the specific high-risk criteria listed in the law

Terms To Know

Cost sharing: The portion of medical costs that a patient must pay, such as copayments, deductibles, or coinsurance.
High-risk subscriber: A man aged at least 40 who has African ancestry, carries the BRCA1/BRCA2 gene, has a family history of prostate cancer as defined by law, or is a military veteran exposed to Agent Orange.
Out-of-network screening: A medical test performed by a doctor or facility that does not have an agreement with the patient's insurance plan; these screenings are excluded from this cost-sharing ban.

Limits and Unknowns

The law only applies to screenings done within the insurer's network of providers.
This rule takes effect on January 1, 2027, and does not apply to policies issued before that date unless they are amended or renewed after then.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HOUSE - Health & Human Services (Adopted)

Adopted

Plain English: Adopted 1

The official amendment file could not be read automatically during the last sync, so only the official amendment metadata is shown right now.

HOUSE - Health & Human Services (Proposed)

Proposed

Plain English: This amendment requires insurance companies to cover prostate cancer screenings at no cost for men who meet specific high-risk criteria starting in January 2027.

Insurance plans cannot charge copays or deductibles for diagnostic prostate cancer screenings if the patient is considered 'high risk'.
The rule applies to hospital service corporations, medical service corporations, health care organizations, and disability insurers.
Men are defined as high-risk if they have a family history of early-onset prostate cancer, carry certain breast cancer genes (BRCA1 or BRCA2), were exposed to Agent Orange, or belong to other specific groups listed in the text.

The amendment text uses brackets and strikeouts that make it difficult to determine exactly which age limits apply without seeing the original bill.
It is unclear if men of African ancestry are included as a high-risk group because the text shows conflicting additions and deletions for this category.

HOUSE - SUB Floor Amend to HHS - Blackman - passed (Adopted)

Adopted

Plain English: This amendment clarifies that insurance companies do not have to cover the full cost of prostate cancer screenings for high-risk patients if they use doctors or hospitals outside their network.

Adds a rule stating that free screening coverage does not apply when using out-of-network providers.
Removes an age requirement, so men over 55 are no longer automatically considered high-risk just because of their age.

The provided text is cut off at the end and may be missing details about other groups or definitions.
The amendment does not explain what specific costs patients will have to pay for out-of-network screenings.

Bill History

2026-03-09 House
House committee of the whole
2026-03-03 House
House minority caucus
2026-03-03 House
House majority caucus
2026-01-26 House
House second read
2026-01-22 House
House Rules: C&P
2026-01-22 House
House Health & Human Services: DPA
2026-01-22 House
House first read

Official Summary Text

HB2617 - 572R - House Bill Summary

ARIZONA HOUSE OF REPRESENTATIVES

57th
Legislature, 2nd Regular Session

Majority Research Staff

House:
HHS DPA 10-2-0-0

HB
2617
: insurance; prostate cancer; cost sharing

Sponsor:
Representative Blackman, LD 7

House
Engrossed

Overview

Prohibits
health care insurers that issue, amend or renew a policy or contract, beginning
January 1, 2027, from imposing cost sharing requirements for diagnostic
prostate cancer screenings for high-risk subscribers.

History

Health care insurers
include disability insurers, group disability
insurers, blanket disability insurers, health care services organizations,
hospital service corporations and medical service corporations (A.R.S. �
20-1379
).

Laws 2014,
Chapter 255
prohibits an insurance policy, contract or
evidence of coverage, that covers cancer medications that are injected or
intravenously administered by a health care provider and covers
patient-administered cancer medications, from requiring a higher copayment,
deductible, or coinsurance amount for the patient-administered medications than
is required for the provider-administered medications. It allows for an
increase in copayment, deductible or coinsurance amounts for cancer medications
if the increase is applied generally to other medical or pharmaceutical
benefits under the contract, policy or evidence of coverage and is not done to
circumvent the legislation. A health insurer is also prohibited from
reclassifying benefits with respect to cancer treatment medications in a manner
that is inconsistent with this legislation. Cancer treatment medications are
prescriptions drugs and biologics that are used to kill, slow or prevent the
growth of cancerous cells (A.R.S. ��
20-841.10,

20-1057.14
,
20-1376.05

and
20-1406.06
).

Provisions

1.

Prohibits a
health care insurer that issues, amends or renews a contract or policy on or
after January 1, 2027, from imposing cost sharing requirements for diagnostic
prostate cancer screenings for high-risk subscribers. (Sec. 1-4)

1.

Defines
high
risk
as men who are at least 40 years of age and to whom any of the
following applies:

a)

are of
African ancestry;

b)

carry the
breast cancer gene, including the BRCA1 or BRCA2 gene; or

c)

have a
family history of prostate cancer. (Sec. 1-4)

2.

Specifies
that
men who have a family history of prostate cancer
, includes a
first-degree relative who:

a)

was diagnosed with prostate
cancer and under the age of 60 at the time of diagnosis;

b)

died of prostate cancer; or

c)

developed a form of cancer that
is known to be associated with an increased risk of prostate cancer. (Sec. 1-4)

2.

Clarifies
that the prohibition on cost sharing for diagnostic prostate cancer screenings for
high-risk subscribers does not apply to out-of-network screenings. (Sec. 1-4)

---------- DOCUMENT FOOTER ---------

AG/LK����������� HB
2617

3/26/2026������� Page
0 House Engrossed

---------- DOCUMENT FOOTER ---------

Current Bill Text

Read the full stored bill text

HB2617 - 572R - H Ver

House Engrossed

insurance; prostate
cancer; cost sharing

State of Arizona

House of Representatives

Fifty-seventh Legislature

Second Regular Session

2026

HOUSE BILL 2617

AN
ACT

amending title 20, chapter 4, article 3,
arizona revised statutes, by adding section 20-841.14; amending title 20,
chapter 4, article 9, arizona revised statutes, by adding SECTION 20-1057.21;
amending title 20, chapter 6, article 4, arizona revised statutes, by adding
section 20-1376.11; amending title 20, chapter 6, article 5, arizona
revised statutes, by adding section 20-1406.11; relating to health
insurance.

(TEXT OF BILL BEGINS ON NEXT PAGE)

Be it
enacted by the Legislature of the State of Arizona:

Section
1.
1. Title
20, chapter 4, article 3, Arizona Revised Statutes, is amended by adding
section 20-841.14, to read:

START_STATUTE
20-841.14.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A hospital service corporation or
medical service corporation that issues, amends or renews a subscription
contract on or after January 1, 2027 may not impose cost sharing requirements
for diagnostic prostate cancer screenings for high-risk subscribers.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer. For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under SIXTY
YEARS of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE

Sec.
2.
2. Title
20, chapter 4, article 9, Arizona Revised Statutes, is amended by adding
section 20-1057.21, to read:

START_STATUTE
20-1057.21.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A health care services
organization that issues, amends or renews An evidence of coverage on or after
January 1, 2027 may not impose cost sharing requirements for diagnostic
prostate cancer screenings for high-risk enrollees.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer. For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under sixty
years of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE

Sec.
3.
3. Title
20, chapter 6, article 4, Arizona Revised Statutes, is amended by adding
section 20-1376.11, to read:

START_STATUTE
20-1376.11.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A disability insurer that issues,
amends or renews a policy on or after January 1, 2027 may not impose cost
sharing requirements for diagnostic prostate cancer screenings for high-risk
insureds.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer. For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under sixty
years of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE

Sec.
4.
4. Title
20, chapter 6, article 5, Arizona Revised Statutes, is amended by adding
section 20-1406.11, to read:

START_STATUTE
20-1406.11.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A group disability insurer or a
blanket disability insurer that issues, amends or renews a policy on or after
January 1, 2027 may not impose cost sharing requirements for diagnostic
prostate cancer screenings for high-risk insureds.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer.� For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under sixty
years of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE